Entasis Therapeutics Ltd

Home » Entasis Therapeutics Ltd

IPO

Entasis Therapeutics Ltd

We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria.

Symbol

ETTX

Price Range
$16.00 - $18.00

Final Shares
4,411,000

Anticipated Date
TBD

Underwriters
Credit Suisse, BMO Capital Markets, SunTrust Robinson Humphrey, Wedbush PacGrow

To view the prospectus for Entasis Therapeutics Ltd IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253